169 related articles for article (PubMed ID: 36269317)
21. Fesoterodine Ameliorates Autonomic Dysreflexia While Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals With Spinal Cord Injury: A Prospective Phase IIa Study.
Walter M; Ramirez AL; Lee AHX; Nightingale TE; Rapoport D; Kavanagh A; Krassioukov AV
J Neurotrauma; 2023 May; 40(9-10):1020-1025. PubMed ID: 36178342
[TBL] [Abstract][Full Text] [Related]
22. New therapeutic options for refractory neurogenic detrusor overactivity.
Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M
Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
[TBL] [Abstract][Full Text] [Related]
23. Early experimental results of using a novel delivery carrier, hyaluronan-phosphatidylethanolamine (HA-PE), which may allow simple bladder instillation of botulinum toxin A as effectively as direct detrusor muscle injection.
El Shatoury MG; DeYoung L; Turley E; Yazdani A; Dave S
J Pediatr Urol; 2018 Apr; 14(2):172.e1-172.e6. PubMed ID: 29482891
[TBL] [Abstract][Full Text] [Related]
24. Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity.
Gutiérrez-Martín P; Vírseda-Chamorro M; Salinas Casado J; Gómez-Rodríguez A; Esteban-Fuertes M
Actas Urol Esp; 2015 May; 39(4):217-21. PubMed ID: 25582926
[TBL] [Abstract][Full Text] [Related]
25. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
[TBL] [Abstract][Full Text] [Related]
26. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
Alvares RA; Silva JA; Barboza AL; Monteiro RT
Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
[TBL] [Abstract][Full Text] [Related]
28. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
29. Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study.
Walter M; Knüpfer SC; Cragg JJ; Leitner L; Schneider MP; Mehnert U; Krassioukov AV; Schubert M; Curt A; Kessler TM
BMC Med; 2018 Apr; 16(1):53. PubMed ID: 29650001
[TBL] [Abstract][Full Text] [Related]
30. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
32. The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury.
Igawa Y; Satoh T; Mizusawa H; Seki S; Kato H; Ishizuka O; Nishizawa O
BJU Int; 2003 May; 91(7):637-41. PubMed ID: 12699475
[TBL] [Abstract][Full Text] [Related]
33. Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.
Peyronnet B; Roumiguié M; Castel-Lacanal E; Guillotreau J; Malavaud B; Marque P; Rischmann P; Gamé X
Neurourol Urodyn; 2016 Feb; 35(2):267-70. PubMed ID: 25524826
[TBL] [Abstract][Full Text] [Related]
34. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Denys P; Castaño Botero JC; Vita Nunes RL; Wachs B; Mendes Gomes C; Krivoborodov G; Tu LM; Del-Popolo G; Thompson C; Vilain C; Volteau M; Kennelly M;
Neurourol Urodyn; 2023 Jan; 42(1):153-167. PubMed ID: 36321799
[TBL] [Abstract][Full Text] [Related]
35. Diastolic blood pressure changes during episodes of autonomic dysreflexia.
Kirshblum S; Eren F; Solinsky R; Gibbs K; Tam K; DeLuca R; Linsenmeyer T
J Spinal Cord Med; 2021 Sep; 44(5):720-724. PubMed ID: 32397863
[No Abstract] [Full Text] [Related]
36. [Efficacy of Botulinum-A toxin injection into bladder to treat neurogenic incontinence in patients with spinal cord injury: comparison of two doses].
Fu G; Wu J; Cong H; Zha L; Li D; Ju Y; Chen G; Xiong Z; Liao L
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3920-3. PubMed ID: 27122214
[TBL] [Abstract][Full Text] [Related]
37. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury.
Jia C; Liao LM; Chen G; Sui Y
Spinal Cord; 2013 Jun; 51(6):487-90. PubMed ID: 23357928
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin in patients at-risk for bladder augmentation: Durable impact or kicking the can?
Bowen DK; Meyer T; Rosoklija I; Sturm R; Chu DI; Cheng EY; Yerkes EB
Neurourol Urodyn; 2022 Aug; 41(6):1406-1413. PubMed ID: 35670258
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity.
Chen SF; Kuo HC
J Formos Med Assoc; 2015 Jul; 114(7):583-9. PubMed ID: 24262922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]